News
kmk-vova/iStock via Getty Images The US FDA has approved AbbVie’s Skyrizi (risankizumab) for use in children six years and older with moderate-to-severe plaque psoriasis or…
It one of the worst weeks for tech stocks of…
Tech rout drags S&P 500 to weekly decline
The announcement comes amid concerns from investors about Lucid’s ability to stay afloat.
The U.S. stock market has suffered a significant correction in every single midterm election year…
U.S. crude stockpiles rose 6.1M barrels last week, API says
As S&P 500 approaches file highs, that is what might derail the stock-market rebound | Invesloan.com
The S&P 500 was back near its all-time high on Tuesday as investors in U.S.…
Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence…
Banks Q1 results offer views of private credit exposure

